首页> 外文期刊>The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation >Breaking through the surface: more to learn about lipids and cardiovascular disease COMMENT
【24h】

Breaking through the surface: more to learn about lipids and cardiovascular disease COMMENT

机译:突破表面:更多了解脂质和心血管疾病 评论

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The human lipidome comprises over tens of thousands of distinct lipid species in addition to total cholesterol and the other conventional lipid traits that are routinely measurable in the peripheral circulation. Of the lipid species considered to exhibit bioactive functions, sphingolipids are a class of molecules that have shown relevance to human disease risk and cardiovascular outcomes in particular. In this issue of the JCI, Poss et al. conducted targeted lipidomics in a case-control study involving over 600 individuals and found a sphingolipid profile that predicted coronary artery disease status. In the context of emerging evidence linking sphingolipid biology with cardiovascular pathophysiology, these results suggest the potential utility of serum sphingolipids as cholesterol-independent markers of risk and even future targets for optimizing cardiovascular health.
机译:除了总胆固醇和其他常规脂质性状外,人类脂质组还包括数以万计的不同脂质种类,这些脂质性状在外周循环中通常可测量。在被认为具有生物活性功能的脂质物种中,鞘脂是一类与人类疾病风险和心血管结局特别相关的分子。在本期JCI中,Poss等人在一项涉及600多人的病例对照研究中进行了靶向脂质组学研究,并发现了预测冠状动脉疾病状态的鞘脂特征。在将鞘脂生物学与心血管病理生理学联系起来的新证据的背景下,这些结果表明血清鞘脂作为胆固醇非依赖性风险标志物甚至优化心血管健康的未来目标的潜在效用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号